Biofrontera Gelecekteki Büyüme
Future kriter kontrolleri 5/6
Biofrontera is forecast to grow earnings and revenue by 70.6% and 22% per annum respectively while EPS is expected to grow by 74.5% per annum.
Anahtar bilgiler
70.6%
Kazanç büyüme oranı
74.5%
EPS büyüme oranı
Pharmaceuticals kazanç büyümesi | 23.7% |
Gelir büyüme oranı | 22.0% |
Gelecekteki özkaynak getirisi | n/a |
Analist kapsamı | Low |
Son güncelleme | 31 Oct 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Biofrontera Inc.'s (NASDAQ:BFRI) Shares Leap 25% Yet They're Still Not Telling The Full Story
Sep 28Further Upside For Biofrontera Inc. (NASDAQ:BFRI) Shares Could Introduce Price Risks After 40% Bounce
Aug 09Take Care Before Jumping Onto Biofrontera Inc. (NASDAQ:BFRI) Even Though It's 29% Cheaper
May 24Biofrontera Inc. (NASDAQ:BFRI) Not Doing Enough For Some Investors As Its Shares Slump 28%
Dec 30The Market Doesn't Like What It Sees From Biofrontera Inc.'s (NASDAQ:BFRI) Revenues Yet As Shares Tumble 43%
Nov 13Can Biofrontera (NASDAQ:BFRI) Afford To Invest In Growth?
Oct 18Biofrontera announces preliminary Q3 product revenue, stock falls ~7% after hours
Oct 05Biofrontera gets notice of allowance for U.S. patent covering a nanoemulsion formulation
Sep 06Biofrontera GAAP EPS of -$0.05, revenue of $4.5M; reaffirms FY22 guidance
Aug 12Biofrontera announces 2Q prelim product revenues
Jul 12Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2026 | 60 | 1 | N/A | N/A | 1 |
12/31/2025 | 48 | -5 | N/A | -6 | 2 |
12/31/2024 | 40 | -15 | N/A | -11 | 2 |
6/30/2024 | 35 | -14 | -19 | -19 | N/A |
3/31/2024 | 33 | -23 | -25 | -25 | N/A |
12/31/2023 | 34 | -20 | -25 | -25 | N/A |
9/30/2023 | 34 | -26 | -24 | -24 | N/A |
6/30/2023 | 29 | -23 | -28 | -28 | N/A |
3/31/2023 | 28 | -14 | -18 | -18 | N/A |
12/31/2022 | 29 | -1 | -16 | -16 | N/A |
9/30/2022 | 28 | -12 | -29 | -29 | N/A |
6/30/2022 | 28 | -26 | -24 | -24 | N/A |
3/31/2022 | 29 | -29 | -25 | -25 | N/A |
12/31/2021 | 24 | -38 | -27 | -27 | N/A |
9/30/2021 | 24 | -23 | -6 | -6 | N/A |
6/30/2021 | 22 | -10 | -6 | -6 | N/A |
3/31/2021 | 19 | -10 | -9 | -9 | N/A |
12/31/2020 | 19 | -11 | -12 | -12 | N/A |
12/31/2019 | 26 | -11 | -38 | -38 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: BFRI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Kazançlar ve Piyasa: BFRI is forecast to become profitable over the next 3 years, which is considered above average market growth.
Yüksek Büyüme Kazançları: BFRI is expected to become profitable in the next 3 years.
Gelir ve Pazar: BFRI's revenue (22% per year) is forecast to grow faster than the US market (8.9% per year).
Yüksek Büyüme Geliri: BFRI's revenue (22% per year) is forecast to grow faster than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if BFRI's Return on Equity is forecast to be high in 3 years time